EUVIMEDSkopri EUVIMED
Video/Audio

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Ying Zhan, Feng Zuo, Zongpeng Zhang, Xiaodan Wu, Yingxin Dai, Tingting Jiao, Qingxue Shi, Zhiguo Wang, Guoxu Zhang

Journal of Visualized Experiments · 2025

DOI: 10.3791/67574 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Ying Zhan and 8 co-authors. Institution: College of Medicine and Biological Information Engineering, Northeastern University. Major MEDLINE topics: Alzheimer Disease, Carbolines, Positron-Emission Tomography, Magnetic Resonance Imaging. Cited 1 times so far (Crossref); 49 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative disorder characterized by cognitive dysfunction, decline in daily living abilities, and behavioral changes, imposing a significant economic and social burden worldwide. One of the primary pathological hallmarks of AD is the accumulation of neurofibrillary tangles formed by hyperphosphorylated tau protein. Positron emission tomography/magnetic resonance imaging (PET/MRI) provides detailed structural and functional information along with specific protein distributions, making it an increasingly valuable tool for AD diagnosis and research. 18F-AV-1451 is a radiotracer specifically designed for tau protein detection in PET imaging of brain tissue. This study presents a detailed protocol for the radiosynthesis of 18F-AV-1451, patient preparation, PET/MRI image acquisition techniques, and its potential applications in AD evaluation. 18F-AV-1451 PET/MRI could aid neurologists in diagnosing AD, assessing disease severity, and gaining insights into its pathological mechanisms. In conclusion, this protocol provides a sensitive, comprehensive, and non-invasive approach for the evaluation of AD, offering valuable insights into disease progression and pathology.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseCarbolinesPositron-Emission TomographyMagnetic Resonance ImagingRadiopharmaceuticalsMultimodal ImagingHumansFluorine RadioisotopesBraintau Proteins

Substances

Carbolines7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleRadiopharmaceuticalsFluorine Radioisotopestau Proteins

Authors and institutions

  • College of Medicine and Biological Information Engineering, Northeastern University.
  • Department of Nuclear Medicine, General Hospital of Northern Theater Command.
  • Department of Nuclear Medicine, General Hospital of Northern Theater Command; wangzhiguo5778@163.com.
  • Department of Nuclear Medicine, General Hospital of Northern Theater Command; zhangguoxu_502@163.com.

Cite

APA

Zhan, Y., Zuo, F., Zhang, Z., Wu, X., Dai, Y., Jiao, T., Shi, Q., Wang, Z., & Zhang, G. (2025). Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451. Journal of Visualized Experiments. https://doi.org/10.3791/67574

Vancouver

Zhan Y, Zuo F, Zhang Z, Wu X, Dai Y, Jiao T, et al. Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451. Journal of Visualized Experiments. 2025. doi:10.3791/67574

BibTeX
@article{Zhan2025,
  author = {Zhan, Ying and Zuo, Feng and Zhang, Zongpeng and Wu, Xiaodan and Dai, Yingxin and Jiao, Tingting and Shi, Qingxue and Wang, Zhiguo and Zhang, Guoxu},
  title = {Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67574}
}
Start for free →